Healthcare Business News

ImmunoGen hires Morris as VP

By Ashok Selvam
Posted: November 27, 2012 - 11:00 am ET

ImmunoGen, Waltham, Mass., has hired Dr. Charles Morris as executive VP and chief development officer.

Morris, whose age wasn't provided, is the former executive VP and chief medical officer at Allos Therapeutics, the Westminster, Colo.-based biotech company that was purchased this year by Henderson, Nev.-based Spectrum Pharmaceuticals. ImmunoGen develops anti-cancer therapeutics. Morris' employment is effective immediately.

Advertisement | View Media Kit


“Charlie has extensive experience leading the strategic development and registration of novel oncology compounds—expertise essential to ImmunoGen with our advancing and expanding product pipeline,” ImmunoGen President and CEO Daniel Junius said in a news release. “We now have three wholly owned clinical-stage compounds, expect to advance our fourth product candidate into the clinic in 2013, and have additional highly promising compounds behind these in our pipeline. We are excited to have Charlie joining ImmunoGen at this important time in our transition to being a product development company.”

What do you think?

Share your opinion. Send a letter to the Editor or Post a comment below.

Post a comment

Loading Comments Loading comments...



Switch to the new Modern Healthcare Daily News app

For the best experience of on your iPad, switch to the new Modern Healthcare app — it's optimized for your device but there is no need to download.